Lord Mandelson announces support for £37m bioscience project

Date posted: 15 Oct 2009

The government''s business secretary Lord Mandelson has revealed plans to develop a new £37 million bioscience research project, which is expected to help towards the creation of new drugs and health products.

The Bioscience Campus in Stevenage is to be given financial backing from the government and a number of other organisations including GlaxoSmithKline and the Wellcome Trust.

Meanwhile, the East of England Development Agency and the Technology Strategy Board are also set to offer funding to help in its development.

The government''s business secretary Lord Mandelson has revealed plans to develop a new £37 million bioscience research project, which is expected to help towards the creation of new drugs and health products.

The Bioscience Campus in Stevenage is to be given financial backing from the government and a number of other organisations including GlaxoSmithKline and the Wellcome Trust.

Meanwhile, the East of England Development Agency and the Technology Strategy Board are also set to offer funding to help in its development.

Lord Mandelson commented that the campus should help strengthen the country''s bioscience industry in the coming years.

He said: "Innovation drives commercial invention [... ] and this joint investment by the public, private and charitable sectors recognises that innovation will be decisive in Britain''s recovery."

The project will encourage firms to work together and share skills in order to create new healthcare innovations.

Speaking at the recent Innovate09 event, Lord Mandelson also suggested that UK universities should be encouraged to team up with businesses in order to apply their research to the commercial sector.ADNFCR-2386-ID-19408755-ADNFCR

Date: 
15 Oct 2009
Sector: 
Market: 

Send to a friend

PatrickFarrant.jpg

Click here to email or call on 01223 225181.

Patrick Farrant

Partner

Our team work with a range of technology clients from early stage through to major deals such as the $500m collaboration and licensing deal between Argenta Discovery and AstraZeneca.
Learn more...